Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VADIVARHE SPECIALITY CHEMICALS Plunges 5%; BSE HEALTHCARE Index Down 0.4%
Mon, 8 Jul 12:12

VADIVARHE SPECIALITY CHEMICALS Plunges 5%; BSE HEALTHCARE Index Down 0.4%Image source: KanawatTH/www.istockphoto.com

VADIVARHE SPECIALITY CHEMICALS share price has plunged 5% and is presently trading at Rs 54.1.

Meanwhile, the BSE HEALTHCARE index is at 38,107.4 (down 0.4%).

Among the top losers in the BSE HEALTHCARE index today are Divis Laboratories (down 3.0%) and CAPLIN POINT (down 2.7%).

GLAND PHARMA (up 1.9%) and MAX HEALTHCARE INSTITUTE (up 1.8%) are among the top gainers today.

Over the last one year, VADIVARHE SPECIALITY CHEMICALS has moved up from Rs 37.3 to Rs 54.1, registering a gain of Rs 16.8 (up 44.9%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,703.5 to 38,107.4, registering a gain of 48.3% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 107.6%), Cadila Healthcare (up 104.0%) and Lupin (up 98.7%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 79,899.5 (down 0.1%).

The top losers among the BSE Sensex today are Titan (down 4.1%) and MUNDRA PORT & SEZ (down 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and ITC.

In the meantime, NSE Nifty is at 24,272.7 (down 0.2%). Titan and Divis Laboratories are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,479.1 to 79,899.5, registering a gain of 14,420.4 points (up 22.0%).

VADIVARHE SPECIALITY CHEMICALS Financial Update...

VADIVARHE SPECIALITY CHEMICALS net profit fell 210.8% YoY to Rs -29 million for the quarter ended December 2021, compared to a loss of Rs 9 million a year ago. Net sales rose 30.5% to Rs 57 million during the period as against Rs 44 million in October-December 2020.

For the year ended March 2023, VADIVARHE SPECIALITY CHEMICALS reported 111.9% increase in net profit to Rs 11 million compared to net loss of Rs 96 million during FY22. Revenue of the company grew 103.6% to Rs 437 million during FY23.

The current Price to earnings ratio of VADIVARHE SPECIALITY CHEMICALS, based on rolling 12 month earnings, stands at -10.8.


Equitymaster requests your view! Post a comment on "VADIVARHE SPECIALITY CHEMICALS Plunges 5%; BSE HEALTHCARE Index Down 0.4%". Click here!